clinicaltrialsarena

Veradermics’ stock up on male hair loss trial success

The drug has now met its endpoints in two Phase III trials. Credit: maxbelchenko / Shutterstock.com Veradermics’ stock was up nearly 6% at market open today after a Phase III trial evaluating its hair ...
clinicaltrialsarena

Cerevance’s novel Parkinson’s drug nets a Phase III win

Cerevance will now speak with the FDA about next steps for solengrapas in Parkinson’s disease. Credit: PeopleImages / Shutterstock.com. Boston-based biotech Cerevance’s first-in-class Parkinson’s ...
clinicaltrialsarena

Merz concludes enrolment in Phase III Xeomin trials for migraine

Migraine involves recurrent attacks of moderate to severe head pain, frequently accompanied by sensitivity to light and sound. Credit: Tunatura/Shutterstock.com. Merz Therapeutics has concluded ...
clinicaltrialsarena

Verastem’s KRAS inhibitor posts wins in mPDAC, mCRC and NSCLC

Verastem Oncology’s KRAS inhibitor has shown promise in several tumour types, including metastatic pancreatic ductal adenocarcinoma (mPDAC), metastatic colorectal cancer (mCRC), and advanced non-small ...
clinicaltrialsarena

Vanda puts anxiety drug’s development on ice after Phase III fail

Vanda has put the late-stage programme for VQW-765 in SAD on ice at it assesses the full dataset. Credit: omahgrafisgk / Shutterstock.com. Vanda Pharmaceuticals has hit pause on a late-stage programme ...
clinicaltrialsarena

Lilly reports Phase IIIb data on Taltz and Zepbound combination

The trial randomised 274 participants to subcutaneous Taltz or the combination, alongside counselling on diet and physical activity. Credit: Pixel-Shot/Shutterstock.com. Eli Lilly and Company has ...
clinicaltrialsarena

FDA clears Caliway’s trial of CBL-514 for localised fat reduction

Recruitment for the trial is set to commence in the third quarter of this year. Credit: Johnstocker Production / Shutterstock.com. The US Food and Drug Administration (FDA) has cleared Caliway ...
clinicaltrialsarena

Pilatus doses first patient in Phase I PLT012 trial for HCC

The trial intends to use the clinical findings to guide the future development of PLT012 across liver disease. Credit: Shidlovski/Shutterstock.com. Pilatus Biosciences has dosed the first patient in ...
clinicaltrialsarena

AbbVie’s Produodopa: Potential first-choice pump for Advanced PD

Produodopa is an alternative to AbbVie’s own Duodopa. Credit: Michael Vi via Shutterstock. On 9 January 2024, AbbVie announced the launch of Produodopa ...
clinicaltrialsarena

Alzheimer’s disease market expected to reach $14.7bn across the 8MM by 2033

A major focus of R&D in the Alzheimer’s disease therapeutic space is preventing the accumulation of amyloid beta.
clinicaltrialsarena

BMS gains two pivotal trial wins in lung disease and rare cancer

BMS announced data from two pivotal trials, with both showing success. Credit: PixelBiss / Shutterstock.com Bristol Myers Squibb (BMS) has seen success in two pivotal trials, one in idiopathic ...
clinicaltrialsarena

Tortugas’ Phase IIb schizophrenia trial of obuprazine meets primary endpoint

Obuprazine functions as a dopamine D2/D3 receptor partial agonist, a 5-HT1A receptor partial agonist, and a 5-HT2A receptor antagonist. Credit: Antonio Marca/Shutterstock.com. Tortugas Neuroscience ...